A comparison of prognostic systems in hepatocellular carcinoma treated with sorafenib.

被引：0
|
作者：
Bagnall, Elizabeth Marie
Gresham, Gillian
Czaykowski, Piotr
Chan, Kelvin K.
Fung, Jennifer
Cuvelier, Susan
Cheung, Winson Y.
机构：
[1] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA
[3] CancerCare Manitoba, Winnipeg, MB, Canada
[4] Univ Toronto, Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[5] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[6] Univ Manitoba, Winnipeg, MB, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e17696
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17696
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A multicenter analysis of prognostic factors in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib.
    Smith, Alan D.
    Chan, Kelvin K.
    Lim, Howard John
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib
    Sansone, Vito
    Tovoli, Francesco
    Casadei-Gardini, Andrea
    Di Costanzo, Giovan Giuseppe
    Magini, Giulia
    Sacco, Rodolfo
    Pressiani, Tiziana
    Trevisani, Franco
    Rimini, Margherita
    Tortora, Raffaella
    Nardi, Elena
    Ielasi, Luca
    Piscaglia, Fabio
    Granito, Alessandro
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2021, 12 (01)
  • [3] A population-based analysis of prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib. Journal
    Smith, Alan D.
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [4] TIME TO PROGRESSION OF AFP IS AN INDEPENDENT PROGNOSTIC FACTOR OF SURVIVAL IN HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB. INTERNAL VALIDATION
    Varela, M.
    Blanco-Garcia, L.
    Castano-Fernandez, O.
    Gonzalez-Dieguez, M. L.
    Cadahia-Rodrigo, V.
    Alvarez-Navascues, C.
    Perez-Alvarez, R.
    Mesa, A.
    Hernandez-Luyando, L.
    Rodriguez, M.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S454 - S454
  • [5] Myopenia as a significant prognostic factor in BCLC-B intermediate-stage hepatocellular carcinoma treated with sorafenib.
    Okada, Mao
    Nakanishi, Hiroyuki
    Kurosaki, Masayuki
    Kirino, Sakura
    Osawa, Leona
    Watakabe, Keiya
    Wang, Wan
    Shimizu, Takao
    Takaura, Kenta
    Takada, Hitomi
    Kaneko, Shun
    Tamaki, Nobuharu
    Yasui, Yutaka
    Tsuchiya, Kaoru
    Itakura, Jun
    Takahashi, Yuka
    Izumi, Namiki
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [6] The prognostic markers in hepatocellular carcinoma treated with sorafenib
    Kawasaki, Takeshi
    Tokunaga, Takayuki
    Fujie, Satomi
    Yoshimaru, Yoko
    Watanabe, Takehisa
    Setoyama, Hiroko
    Tateyama, Masakuni
    Tanaka, Motohiko
    Sasaki, Yutaka
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 419 - 419
  • [7] Effect of specialized nursing intervention on the prognosis of hepatocellular carcinoma patients treated with sorafenib.
    Pang, Xufeng
    Li, Guizhi
    Lv, Yaqing
    Wang, Juanjuan
    Wei, Lili
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (02): : 791 - 796
  • [8] KEYNOTE-224: Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib.
    Zhu, Andrew X.
    Finn, Richard S.
    Cattan, Stephane
    Edeline, Julien
    Ogasawara, Sadahisa
    Palmer, Daniel H.
    Verslype, Chris
    Zagonel, Vittorina
    Rosmorduc, Olivier
    Vogel, Arndt
    Sarker, Debashis
    Verset, Gontran
    Chan, Stephen Lam
    Knox, Jennifer J.
    Daniele, Bruno
    Ebbinghaus, Scot
    Ma, Junshui
    Siegel, Abby B.
    Cheng, Ann-Lii
    Kudo, Masatoshi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [9] Baseline neutrophil-to-lymphocyte ratio (NLR) and early toxicity as prognostic factors in advanced hepatocellular carcinoma patients treated with sorafenib.
    Bruixola, Gema
    Mauricio Nino, Oscar
    Diaz-Beveridge, Robert
    Reche, Encarnacion
    Salvador, Carmen
    Escoin, Corina
    Akhoundova, Dilara
    Segura, Angel
    Gimenez, Alejandra
    Aparicio, Jorge
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [10] Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib
    Labeur, Tim A.
    Berhane, Sarah
    Edeline, Julien
    Blanc, Jean-Frederic
    Bettinger, Dominik
    Meyer, Tim
    Van Vugt, Jeroen L. A.
    Ten Cate, David W. G.
    De Man, Robert A.
    Eskens, Ferry A. L. M.
    Cucchetti, Alessandro
    Bonnett, Laura J.
    Van Delden, Otto M.
    Klumpen, Heinz-Josef
    Takkenberg, R. Bart
    Johnson, Philip J.
    LIVER INTERNATIONAL, 2020, 40 (01) : 215 - 228
12345